Arthritis & Rheumatology

Arthritis & Rheumatology
Name	Arthritis & Rheumatology
Field	Rheumatology
Symptoms	Joint pain; stiffness; swelling
Onset	Variable
Causes	Autoimmunity; infection; degeneration
Diagnosis	Clinical, imaging, serology
Treatment	Pharmacotherapy; physical therapy; surgery

Arthritis & Rheumatology Arthritis & Rheumatology comprises clinical syndromes of joint and connective tissue disorders managed within specialties such as Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Massachusetts General Hospital, and Stanford Health Care. Major research efforts are conducted at institutions including National Institutes of Health, University of Oxford, Karolinska Institutet, Harvard Medical School, and University of Toronto. Influential figures include investigators from American College of Rheumatology, European League Against Rheumatism, World Health Organization, Bill & Melinda Gates Foundation, and foundations like Arthritis Foundation.

Overview

The field integrates knowledge from clinical centers like Royal National Hospital for Rheumatic Diseases, Guy's Hospital, Moorfields Eye Hospital, Seattle Children's Hospital, and research hubs such as Institut Pasteur, Max Planck Society, Imperial College London, University of California, San Francisco, and John Innes Centre. Patient advocacy intersects with organizations like National Health Service, Centers for Disease Control and Prevention, Crohn's & Colitis Foundation, American Academy of Pediatrics, and European Medicines Agency in shaping guidelines. Landmark trials at Mayo Clinic and National Health Service settings have informed standards endorsed by American College of Rheumatology and European League Against Rheumatism.

Classification and Types

Classification schemes used by groups such as World Health Organization and specialty societies categorize inflammatory conditions like Rheumatoid arthritis (studied at Karolinska Institutet), autoimmune connective tissue diseases like Systemic lupus erythematosus (researched at University of Michigan), crystal arthropathies including Gout (investigated at University College London), and degenerative disorders such as Osteoarthritis (studied at Johns Hopkins Hospital). Other categories include spondyloarthropathies like Ankylosing spondylitis (research sites include University of Oxford), pediatric disorders like Juvenile idiopathic arthritis (managed at Great Ormond Street Hospital), and reactive entities associated with infections tracked by Centers for Disease Control and Prevention.

Pathophysiology and Risk Factors

Pathogenic mechanisms have been elucidated through work at National Institutes of Health, Cold Spring Harbor Laboratory, Sanger Institute, Broad Institute, Dana-Farber Cancer Institute, and Pasteur Institute. Autoimmune processes implicating HLA alleles were characterized in cohorts from University of Cambridge, Karolinska Institutet, and McGill University. Environmental and infectious risk factors identified in studies at Harvard School of Public Health and London School of Hygiene & Tropical Medicine include associations with pathogens studied at Pasteur Institute and exposure patterns documented by World Health Organization. Genetic risk loci discovered in consortia including 1000 Genomes Project and International HapMap Project inform personalized medicine approaches trialed at Stanford University and Massachusetts General Hospital.

Diagnosis and Clinical Evaluation

Diagnostic pathways developed by American College of Rheumatology and European League Against Rheumatism incorporate history-taking frameworks used at Mayo Clinic, examination techniques taught at Johns Hopkins Hospital, and imaging protocols from Royal College of Radiologists. Laboratory testing paradigms draw on assays standardized by World Health Organization and reference labs at Centers for Disease Control and Prevention and National Institutes of Health. Advanced imaging and interventional diagnostics from Memorial Sloan Kettering Cancer Center, UCLA Medical Center, and Karolinska University Hospital support evaluation of complex cases.

Treatment and Management

Therapeutic strategies originate from trials at National Institutes of Health, Mayo Clinic, Massachusetts General Hospital, Cleveland Clinic, and industry partnerships with companies regulated by European Medicines Agency and Food and Drug Administration. Pharmacologic options include disease-modifying agents developed in collaborations involving Biogen, Pfizer, Roche, AbbVie, and Johnson & Johnson and implemented in clinical programs at Johns Hopkins Hospital and UCLA Health. Nonpharmacologic management is coordinated with rehabilitation services at Spaulding Rehabilitation Hospital, Royal National Orthopaedic Hospital, Glenfield Hospital, and community programs supported by Arthritis Foundation and National Health Service. Surgical interventions are performed at specialty centers including Hospital for Special Surgery, Moorfields Eye Hospital (for ocular complications), and orthopaedic units at Addenbrooke's Hospital.

Prevention and Prognosis

Prevention initiatives draw on public health efforts by Centers for Disease Control and Prevention, World Health Organization, National Institutes of Health, and community outreach by Arthritis Foundation and European League Against Rheumatism. Prognosis varies and is informed by longitudinal cohorts maintained at Framingham Heart Study sites, registers like the Swedish Rheumatology Quality Register, and outcome studies from Duke University School of Medicine, Columbia University Irving Medical Center, and University of Sydney. Multidisciplinary care pathways developed by American College of Rheumatology, European League Against Rheumatism, National Health Service, and academic centers aim to improve function and reduce disability.

Category:Rheumatology